Hepatic Sarcoidosis
- PMID: 26357609
- PMCID: PMC4521279
- DOI: 10.14218/JCTH.2013.00016
Hepatic Sarcoidosis
Abstract
Sarcoidosis is a multisystem disease characterized by the presence of non-caseating granulomas in affected organs. Pulmonary involvement is the most common site of disease activity. However, hepatic involvement is also common in sarcoidosis, occurring in up to 70% of patients. Most patients with liver involvement are asymptomatic. Therefore, the majority of cases are discovered incidentally, frequently by the finding of elevated liver enzymes. Pain in the right upper quadrant of the abdomen, fatigue, pruritus, and jaundice may be associated with liver involvement. Portal hypertension and cirrhosis are complications linked to long-standing hepatic sarcoidosis. Liver biopsy is usually required to confirm the diagnosis. It is important to differentiate hepatic sarcoidosis from other autoimmune and granulomatous liver diseases. Not all cases of hepatic sarcoidosis require treatment. For symptomatic patients, the first line treatment includes corticosteroids or ursodeoxycholic acid. Various immunosuppressant agents can be used as second line agents. Rarely, severe cases require liver transplantation.
Keywords: Epitheloid; Granuloma; Sarcoid.
Conflict of interest statement
Figures
References
-
- Culver DA. Sarcoidosis. Immunol Allergy Clin North Am. 2012;32:487–511. - PubMed
-
- Baughman RP, Lower EE. Sarcoidosis. Harrison's Principles of Internal Medicine. 2008:2135–2142.
-
- Perng RP, Chen JH, Tsai TT, Hsieh WC. Sarcoidosis among Chinese in Taiwan. J Formos Med Assoc. 1997;96:697–699. - PubMed
-
- Perng RP, Chou KT, Chu H, Chung YM. Familial sarcoidosis in Taiwan. J Formos Med Assoc. 2007;106:499–503. - PubMed
-
- Rybicki BA, Major M, Popovich J, Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–241. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources